AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GBM Resources Ltd

0.037

+0.0038.82%

Volume:52.88M

Turnover:1.83M

Market Cap:174.78M

PE:-11.03

High:0.037

Open:0.035

Low:0.034

Close:0.034

52wk High:0.068

52wk Low:0.006

Shares:4.72B

Float Shares:1.72B

Volume Ratio:5.87

T/O Rate:3.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.003

EPS(LYR):-0.003

ROE:-15.07%

ROA:-5.83%

PB:4.28

PE(LYR):-11.03

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

GBM Resources Begins Stage Two Drilling Program at Queensland Project, Shares Jump 8%

MT Newswires Live

Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial

GBM Resources Says Drilling At Queensland Gold Project Intersects Mineralization Outside Existing Mineral Resource Estimate

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GBM.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GBM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GBM.AU\",,,,,undefined,":{"symbol":"GBM.AU","market":"AU","secType":"STK","nameCN":"GBM Resources Ltd","latestPrice":0.037,"timestamp":1771823520000,"preClose":0.034,"halted":0,"volume":52882783,"delay":0,"changeRate":0.08823529411764693,"nameEN":"GBM Resources Ltd","floatShares":1719625202,"shares":4723825443,"eps":-0.003354,"marketStatus":"Closed","change":0.003,"latestTime":"02-23 16:12:00 AEDT","open":0.035,"high":0.037,"low":0.034,"amount":1830622,"amplitude":0.088235,"askPrice":0.037,"askSize":1071754,"bidPrice":0.035,"bidSize":1280000,"shortable":3,"etf":0,"ttmEps":-0.003354,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771887600000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.034,"openAndCloseTimeList":[[1771801200000,1771822800000]],"volumeRatio":5.869496,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GBM.AU\",,,,,undefined,":{"symbol":"GBM.AU","floatShares":1719625202,"roa":"-5.83%","roe":"-15.07%","lyrEps":-0.003354,"volumeRatio":5.869496,"shares":4723825443,"dividePrice":0,"high":0.037,"amplitude":0.088235,"preClose":0.034,"low":0.034,"week52Low":0.006,"pbRate":"4.28","psRate":"15226.20","week52High":0.068,"institutionHeld":0,"latestPrice":0.037,"committee":0.088549,"eps":-0.003354,"divideRate":0,"volume":52882783,"delay":0,"ttmEps":-0.003354,"open":0.035,"prevYearClose":0.031,"prevWeekClose":0.034,"prevMonthClose":0.037,"prevQuarterClose":0.031,"fiveDayClose":0.033,"twentyDayClose":0.042,"sixtyDayClose":0.033,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GBM.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-10-13","symbol":"GBM.AU","reason":null,"defaultRemindTime":1602543600000,"announcedDate":"2020-10-12","type":"delisting","dateTimestamp":1602507600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GBM.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GBM.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612231047","title":"FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2612231047","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612231047?lang=en_us&edition=fundamental","pubTime":"2026-02-20 07:27","pubTimestamp":1771543620,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited  today announces its financial results for the year ended December31, 2025.Group performance2: Double-digit revenue growth and positive adjusted operating cash flow. Revenue of US$803.8 million, up by 56%3 and achieving upsized full year guidance4.US$157.1 million invested in research and development (R&D) product development for late-stage therapeutics and precision medicine pipeline assets5, in line with stated FY 2025 guidance.Adjusted EBITDA6 of US$39.5 million, reflective of increased operating expenditure driven by strategic acquisitions, investment in commercial infrastructure and research and development (R&D).Year-end cash balance of US$141.9 million following US$246.4 million of strategic investments (M&A) and cash generated from operating activities of US$34.5 million before the final contingent consideration payment to Advanced Nuclear Medicine Ingredients  of US$51.8 million7","market":"sg","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/fy-2025-results-strong-commercial-growth-focused-pipeline-investment-302693191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7116","BK4139","BK7067","CE","TLX.AU","ASX.AU","BK4585","BK4543","BK4588","BK4109","BK7506","ASX","BLA.AU","BK7095","TMS.AU","BK7104","BK4526","GBM.AU","TAT","SEC.AU","TAT.AU","BK4141","BK7039","TLX"],"gpt_icon":0},{"id":"2610998251","title":"GBM Resources Begins Stage Two Drilling Program at Queensland Project, Shares Jump 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610998251","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610998251?lang=en_us&edition=fundamental","pubTime":"2026-02-12 08:18","pubTimestamp":1770855535,"startTime":"0","endTime":"0","summary":"GBM Resources  began a multi-rig 50,000-meter stage two drilling program at the Twin Hills project in Queensland, according to a Thursday Australian bourse filing.The program consists of around 20,000 meters of reverse circulation and 30,000 meters of diamond drilling. The drilling will prioritise the definition and expansion of near-surface mineralisation suitable for open-pit mining.Its shares climbed 8% in recent trading on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GBM.AU","SSI","BK7104"],"gpt_icon":0},{"id":"2608364926","title":"Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2608364926","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608364926?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:00","pubTimestamp":1770210000,"startTime":"0","endTime":"0","summary":"Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA.CALGARY, AB and BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, is supporting aworld-first clinical trialevaluating personalized mRNA cancer vaccines for children with advanced and treatment-resistant brain tumors.ThePaedNEO-VAX trial, funded by Providence Therapeutics, in combination with the Australian Government and a host of philanthropic donors, is the first multi-site pediatric study to test individualized mRNA vaccines designed specifically for each child's cancer.The trial is co-led by The University of Queensland and the South Australian Health and Medical Research Institute  and will begin in March 2026 across seven pediatric hospitals in Queensland, South Australia, New South Wales, Victoria, and Western Australia. It is sponsored by the Australia & New Zealand C","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/providence-therapeutics-announces-world-first-personalized-pediatric-mrna-cancer-vaccine-trial-302678309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GBM.AU","XJO.AU","BK7104","LENZ","BK4539","BK4007","XKO.AU","XAO.AU"],"gpt_icon":0},{"id":"2607772643","title":"GBM Resources Says Drilling At Queensland Gold Project Intersects Mineralization Outside Existing Mineral Resource Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2607772643","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607772643?lang=en_us&edition=fundamental","pubTime":"2026-01-29 13:31","pubTimestamp":1769664690,"startTime":"0","endTime":"0","summary":"GBM Resources  said stage one drilling at the 309 deposit, within the Twin Hills gold project in Queensland, intersected high-grade mineralization over 100 meters outside of the existing mineral resource estimate, according to a Thursday Australian bourse filing.It encountered an intercept of 37 meters at 5 grams per tonne grade of gold from 225 meters.The stage one drilling results provided structural information and vectors for targeting deeper \"feeder zone\" mineralization below the existing mineral resource estimate.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GBM.AU","BK7104"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GBM.AU\",params:#limit:6,delay:true,,,undefined,":[]}}